Abstract Submission: Rules and Policies

Abstracts for ASHG 2017 were due June 7, 2017 at 8:00 pm U.S. Eastern Time.

All authors will be asked to confirm the following when submitting an abstract: (1) I have read, understand, and agree to the rules and policies; (2) I am submitting this abstract with the intent of attending the 2017 Annual Meeting and presenting; and (3) I confirm that each co-author has been informed of this abstract submission and has agreed to all information as it was submitted.

NOTE: Authors who submit abstracts are not automatically registered for the meeting. In order to participate in the meeting and make their presentations, authors must register for the meeting and cover the costs of hotel and travel.

  1. Abstracts must be submitted with the intention that they will be presented if selected. First authors are expected to attend the meeting and make the presentation. Authors should not submit abstracts if they do not plan to attend the meeting. Authors who cannot present as scheduled must notify the ASHG office in advance; authors who fail to do so may not be invited to present at future meetings. Substitution of the presenting/first author in platform and plenary presentations requires prior written approval from the Program Committee Chair. Substitution is not allowed without prior written approval.

  2. An individual may be first/presenting author of only one abstract. If an abstract includes co-authors, the presenting author’s name should be the first name to appear in the author listing. 

  3. There is no limit to the number of times an individual may appear as co-author on abstracts. The first author must inform and have agreement from all co-authors of the abstract submission. The first author will be required to confirm this information when submitting the abstract. The first author is also responsible for notifying all authors of any and all correspondence relating to this abstract submission.

  4. With regard to research using human subjects, ASHG endorses the protections embodied in the Basic Principles of the Declaration of Helsinki and their expansion in the regulations governing research supported by the U.S. Government (45 CFR Part 46; 56 FR 28003). ASHG does not endorse and will not publish the results of research that was not conducted in accordance with these principles. Investigations involving animals reported in abstracts must have been conducted in conformance with approved principles of the care and use of animals in research.

  5. With regard to research in which a gene or SNP is identified, the first/presenting author must present the gene symbol and/or name the identified marker at the meeting. Authors who do not conform to this policy at the meeting will be subject to sanctions as determined by the Program Committee.

  6. A complete abstract should include a statement of purpose, methods used, and a summary of results in sufficient detail to support the conclusion. Statements such as "results will be described" should be avoided.

  7. Prior Publication: Results or studies that have been published or that will be accepted for publication elsewhere prior to the submission deadline of June 7, 2017 must be disclosed and the author should make clear what new information will be presented. For purposes of this policy:

    1. Material posted on a preprint server is NOT considered previously published.

    2. Abstracts that have been accepted for presentation at other conferences are considered previously published. 

  8. Review of Abstracts: All abstracts are reviewed by at least one Program Committee member and three ad hoc reviewers. The reviewing process is strictly confidential. The Program Committee reviews all abstracts submitted for presentation and determines whether an abstract is suitable for an oral or poster presentation. The Program Committee reserves the right to decline a presentation to any submitted abstracts that lack scientific content or merit, or that merely announce the availability of a resource or service.

  9. Abstract Programming: When submitting an abstract, authors will indicate whether they wish the abstract to be considered for an oral or poster presentation. The Program Committee will make the final decision. If there is any uncertainty about the first author’s ability to attend the meeting, a poster presentation should be selected. Click here to see more details about abstract programming.

  10. Abstract Licensing Agreement/Copyright Policy: In consideration of acceptance of the abstract by The American Society of Human Genetics (ASHG), the submitting author grants ASHG a nonexclusive, perpetual, worldwide license to copy, reproduce, and publish the abstract in ASHG's online or print publication of ASHG Annual Meeting abstracts and/or other compilations or collective works to be assembled and owned by ASHG (together, "Collective Works") in any form or medium now existing or hereafter created throughout the world. The submitting author understands and agrees that ASHG shall own all rights, including copyright, in and to the Collective Works, including the right to: 

    1. Distribute, reproduce, license, display, perform, lend, lease, or transfer rights to the Collective Works to third parties,

    2. Prepare derivative works of the Collective Works, and

    3. Register the Collective Works in ASHG's own name with the U.S. Copyright Office. 

    It is understood that the submitting author and/or third parties with copyrights shall retain copyright in and to the abstract contributed by the submitting author to a Collective Work. The submitting author affirms that s/he is the author and owner of the abstract and holds all copyrights in and to the abstract, or has secured any third-party permissions necessary to grant ASHG the above rights. The submitting author is responsible for providing any related third party with a copy of this grant of rights.

  11. Publication of Abstracts: Abstracts selected for presentation and publication will be available on the ASHG 2017 website in early September. At this time, your abstract and all information will become a matter of public record and may be referenced by ASHG, media relations staff, and others. Please review the Abstract Licensing Agreement/Copyright Policy above, as well as the Embargo Guidelines.

  12. Meeting Capture and Photography Policy: For platform speakers who wish to share their slides with fellow attendees, ASHG will set up a secure, slide-sharing website. Poster authors should note that unless otherwise indicated, attendees will have permission to take photos of posters. Our full photography policy can be viewed here.